Cuts in
direct-to-consumer advertising for J&J's prescription-drug and medical-device brands account for most of the reduction, but a closer look shows the marketer has moved quickly away from its heavy
reliance on traditional media, particularly TV.
Overall, J&J's global ad spending dropped around 10% to $1.9 billion last year, even as sales rose 6% to $53.2 billion. But the bigger drop in the U.S. suggests a lot of its marketing budget went to unmeasured media, like search and other direct marketing. In addition, the move to sit out last year's upfront (it will do it again this year) gives it more flexibility, as it isn't locked into TV commitments.
advertisement
advertisement